Intravenous Paraquat Poisoning
阿维菌素与有机磷农药混配中毒的临床研究
于接触组(JP<O.01),混配农药中毒高于有机磷农药中 毒组(P<0.01),两者比较差异有统计学意义(P< 0.0I)。提示有机磷中毒和混配后农药巾毒均可产生全 身炎症反应,进一步说明全身炎症反应是各种中毒危重 症中不可忽视的问题。
eonl州¥Oll phnsphorus pesticide.and search for∞effective detoxification method.Methods The
study of 59 cases with acute poisoning by
hybrid biolo画eal pesticide almrn∞tin mixed organophosphons pesticide.and the blood biochemical index,eholinemerase,plasma inflammatory
与第3组比较,差异无统汁学意义(P>0.05)。CHE 活性测定、CRP与APACHE II评分3组问,差异有统
有不同程度的眼部症状,用氯霉素眼药后第2 d均缓 计学意义(P<O.01)。
解。第2、第3组均以有机磷中毒症状为主,第3组临床 表1 实验室数据比较(i±s)
。。.
“”’
“
第1 d
CHE活性(U/1.) 第2 tl
出现焦虑、烦躁、嗜睡、精神抑郁、惊厥、共济失调,甚评分的分值差异有统计学意义,与姜红等…研究结果相
至昏迷等神经系统症状¨。】。阿维菌素经皮毒性较
符。这与国内外一些学者对危重病评价中的研究结果
小,对眼睛及皮肤的刺激性较大。尤其对眼睛角膜呵 相符p。81,表明该评分能预测中毒患者的预后。③CRP
造成不可逆的损伤。有机磷农药与阿维菌素混配后是一种非常敏感的炎症和组织损伤标记物¨1。由于有
血必净注射液对急性百草枯中毒患者的多器官保护作用
2005
ⅣAⅣG沌,ZH以。胁挖. E聊rgP,王掣D印口疗僦疗t D,Sk挖∥行g胁印i缸z D,吼i咒口
to【)ecember patients).
201 O
were
randomly
divided
into
treatment
group
(18 patients)and control group(17 treatment group,besides intravenous drip, twice
。297。
病史。入院后按随机原则分为对照组(17例)和治疗 组(18例),两组患者的年龄、服药量、服药后至就诊
时间、发生急性呼吸窘迫综合征(ARDS)和多器官
比较(表2):与对照组比较,治疗组3 d时血浆 MDA水平低于对照组,7 d时二者比较差异仍有统
计学意义(均P<0.05);治疗组治疗3、7、14 d时血
I、Ⅱ型上皮细胞被破坏,肺泡间隔内大量中性粒细 胞浸润,形成广泛的肺泡炎。此后逐渐出现广泛肺泡
1.3检测指标及方法:①动态监测动脉血氧饱和度 (SaO。)、肾功能、肝功能、心肌酶学;②2个或2个
以上器官功能障碍,无干预情况下不能维持内环境
稳定的为MODS,比较两组患者的病死率;③检测 血浆丙二醛(MDA)和超氧化物歧化酶(SOD)水平, 严格按照试剂盒说明书操作。 1.4统计学方法:应用SPSS 16.o统计软件处理数 据。计量资料以均数土标准差(z士s)表示,组间比较 采用成组设计t检验;计数资料比较采用影检验; 尸<O.05为差异有统计学意义。
保护胃肠道黏膜及大剂量糖皮质激素治疗,并尽早
行血流灌流(HP),每日3 h,连用5 d。治疗组在以上 3讨论
去甲肾上腺素在百草枯中毒致肺纤维化小鼠模型中的作用研究
去甲肾上腺素在百草枯中毒致肺纤维化小鼠模型中的作用研究作者:汤涛陈铜兵王辉来源:《中国医药科学》2022年第08期[摘要]目的探讨去甲肾上腺素(NE)在百草枯中毒导致肺纤维化中的作用。
方法选取苏州大学附属第三医院急诊科收治的41例百草枯中毒患者和6只实验小鼠的血浆,實验组和对照组小鼠各3只,实验组用百草枯处理,高效液相色谱电化学法检测血浆中 NE 浓度。
采用微渗透泵构建小鼠模型,实验组9只,对照组小鼠3只,实验组用百草枯加 NE 处理,对照组仅用百草枯处理。
模拟 NE 受体阻断剂普萘洛尔对百草枯中毒引起的肺纤维化模型,实验组和对照组小鼠各18只,实验组用百草枯加 NE 加普萘洛尔处理,对照组中普萘洛尔换成等量的乙醇。
结果研究显示百草枯中毒患者的 NE 水平显著提高,而中毒实验小鼠 NE 并没有提高。
体外细胞实验显示, NE 在体外可诱导人肺泡Ⅱ型上皮细胞发生上皮间质转化,从而协同百草枯中毒致肺纤维化,小鼠实验发现实验组用 NE 处理的小鼠肺纤维化程度高于对照组。
普萘洛尔实验显示,实验组加了普萘洛尔后百草枯中毒小鼠的肺纤维化程度明显低于对照组。
结论 NE 可能是导致临床百草枯中毒致肺纤维化疗效不佳的重要原因,普萘洛尔在临床上对百草枯中毒所致的肺纤维化有一定的预防作用。
[关键词]百草枯;肺纤维化;去甲肾上腺素;间质转化;普萘洛尔[中图分类号] R965 [文献标识码] A [文章编号]2095-0616(2022)08-0027-05The study on effect of norepinephrine in mouse models of pulmonary fibrosis induced by paraquat poisoningTANG Tao CHEN Tongbing WANG HuiDepartment of Pathology,the First People’s Hospital of Changzhou, Jiangsu, Changzhou 213003, China[Abstract] Objective To investigate the effect of norepinephrine in pulmonary fibrosis induced by paraquat poisoning. Methods The plasma of 41 paraquat poisoning patients who were admitted to the emergency department of the Third Affiliated Hospital of Soochow University and plasma of 6 experimental mice were selected, with 3 mice each in the experimental group and the control group. The experimental group was treated with paraquat, and the high-performance liquid chromatographywith electrochemical detection was used to determine the concentration of norepinephrine in plasma.A micro-osmotic pump was used to construct a mouse model, with 9 mice in the experimental group and 3 mice in the control group. The experimental group was treated with paraquat plus norepinephrine, and the control group was treated with paraquat only. A model of pulmonary fibrosis induced by paraquat poisoning with propranolol, a norepinephrine receptor blocker, was established. There were 18 mice in each of the experimental group and the control group. The experimental group was treated with paraquat plus norepinephrine plus propranolol, and propranolol in the control group was replaced with the same amount of ethanol. Results The study showed that the level of norepinephrine in paraquat poisoned patients was significantly increased, while it did not increase in poisoned experimental mice. In vitro cell experiments showed that norepinephrine induced epithelial-mesenchymal transition in human alveolar type Ⅱ epithelial cells in vitro, thereby cooperating with paraquat poisoning to induce pulmonary fibrosis. Experiments in mice found that the degree of pulmonary fibrosis in mice treated with norepinephrine in the experimental group was higher than that in the control group. The propranolol experiment showed that the degree of pulmonary fibrosis in the paraquat poisoned mice in the experimental group with addition of propranolol was significantly lower than that of the control group. Conclusion Norepinephrine may be an important reason for the poor efficacy of clinical pulmonary fibrosis induced by paraquat poisoning. Propranolol has a certain clinical preventive effect on pulmonary fibrosis induced by paraquat poisoning.[Key words] Paraquat; Pulmonary fibrosis; Norepinephrine; Mesenchymal transition; Propranolol百草枯(paraquat, PQ)中毒是较常见的农药中毒之一,毒性可累及全身多个脏器,但主要以肺为靶器官,早期临床表现为急性肺损伤,后期可出现肺泡内和肺间质纤维化[1-2]。
血必净注射液疗百草枯中毒患者疗效观察
department had admitted 49
poisoning.We randomly
divided these patients into two only
one
groups had received the routine
treatment,and
observed
group had
received the additional
周的动脉血气,肝功能,肾功能,死亡率的变化及趋势,并将两组进行比较。
结果
血必净治疗组与常规治疗组患者相比较,前者不同时间段的血肌酐、黄疸指 数水平明显低于对照组。血必净治疗组患者的动脉血氧分压的下降水平和速度远 较对照组平缓。血必净治疗组患者各个时间段及总死亡率远较对照组低。
结论
在常规规范化治疗的基础上使用血必净可以明显改善百草枯中毒患者的 肝、肾功能损伤,减轻急性肺损害,降低患者的死亡率。
指导教师签名:
日
期:
基一
・论文・
血必净注射液治疗百草枯中毒患者疗效观察
刖吾 百草枯(Paraquat,PQ),是吡啶类除草剂,有效成分为:1.1—4.4-二联吡啶。 是目前全世界使用最广泛的除草剂之一,皮肤接触,呼吸道吸入和口服均可造成 中毒,且百草枯中毒无特殊解毒剂。人口服致死量为30—40mg/kg【11。百草枯中毒 患者大多有急性肝、肾功能衰竭,急性肺泡炎和不可逆转的肺纤维化等重要脏器 损害,死亡率极高。血必净是一种新型的中药注射液,药理证明,活血化瘀药能 改善微循环,减少血小板聚集,减少炎性渗出,改善局部血液循环,增强网状内 皮细胞的吞噬和吸附能力。此外,还有研究显示,血必净具有强效抗内毒素作 用,提高超氧化物歧化酶活性,调节过高或过低的免疫反应‘21。 本文通过对我院急诊科从2007年1月至tJ2009年3月收治入院治疗的49位的百草 枯中毒患者使用血必净注射液治疗的疗效分析,观察血必净治疗对百草枯毒患者
血必净注射液联合乙酰半胱氨酸对急性百草枯中毒肝肾损伤的作用
血必净注射液联合乙酰半胱氨酸对急性百草枯中毒肝肾损伤的作用龚升玄;魏书堂【期刊名称】《西北药学杂志》【年(卷),期】2024(39)1【摘要】目的探讨血必净注射液联合乙酰半胱氨酸(acetylcysteine,AC)对急性百草枯中毒(acute paraquat poisoning,APP)肝肾损伤的作用。
方法回顾性分析救治的80例APP患者的临床资料,按治疗方式不同分为AC组(n=39,常规治疗联合AC)、联合组(n=41,在AC组治疗的基础上加用血必净注射液)。
比较2组治疗前、治疗2周后呼吸指标[动脉血氧分压(PaO_(2))、氧合指数]、炎症因子水平[白细胞介素-6(interleukin-6,IL-6)、转化生长因子β_(1)(transforming growth factor-β_(1),TGF-β_(1))]和肝肾功能指标[丙氨酸氨基转移酶(glutamic pyruvic transaminase,GPT)、天冬氨酸氨基转移酶(glutamic oxaloacetic transaminase,GOT)、血肌酐(serum creatinine,Scr)和肾小球滤过率(estimated glomerular filtration rate,eGFR)],并观察预后。
结果治疗后,2组PaO_(2)、氧合指数和eGFR均较治疗前明显升高(P<0.05),且联合组均明显高于AC组(P<0.05);治疗后,2组血清IL-6、TGF-β_(1)水平和GPT、GOT、Scr均较治疗前明显降低(P<0.05),且联合组均明显低于AC组(P<0.05);联合组1个月内脏器功能衰竭发生率(32.56%vs.56.41%)、病死率(60.98%vs.82.05%)均明显低于AC组(P<0.05)。
结论血必净注射液联合AC治疗APP,可明显减轻肝肾损伤,有效抑制炎症反应,显著提高患者的存活率。
【百草枯中毒患者血清补体及免疫球蛋白含量的变化及意义】 血清补体免疫球蛋白
《【百草枯中毒患者血清补体及免疫球蛋白含量的变化及意义】
血清补体免疫球蛋白》
摘要:百草枯中毒(paraquat poisoning,PQ)仍是国内外高致死性的临床常见急重症,其中毒后的病死率大于80%,由于
目前百草枯中毒的致病机制仍缺乏系统深入的认识,目前尚无特效治疗手段,未安装PDF浏览器用户请先下载安装原版全
文
前言百草枯中毒(paraquat poisoning,PQ)仍是国内外高致死性的临床常见急重症,其中毒后的病死率大于80%。
由于目前百草枯中毒的致病机制仍缺乏系统深入的认识,目前
尚无特效治疗手段。
补体作为集体非特异性免疫中重要组成一员,与免疫球蛋白和抗体等协同
作用可增强机体免疫功能,但补体的大量激活即过度表达也可介导大量炎症因子、趋化因子、
细胞因子等的产生,在百草枯中毒发生与发展中的作用目前尚未得到重视。
本研究旨在通过分
析百草枯中毒患者补体及免疫球蛋白在血清中水平的变化,探讨补体激活在百草枯中毒致死机
制中的作用及地位,以期为百草枯中毒的救治研究提供新的理论依据。
本文为全文原貌未
安装PDF浏览器用户请先下载安装原版全文
.。
PQP诊治专家共识与规范(协和)
HD+HP 住院几天后,症状好转,血PQ浓度0.03mg/L 8.29右肺移植 9.1(术后48h,出现中毒症状后21天)血PQ浓度0.2mg/L,较前升高7倍
9.3(术后4d,出现中毒症状后23天)移植肺出现渗出性病变,肺活检考虑PQ损害 ECMO+HP+间断HD
9.12(术后13d,出现中毒症状后32天)血PQ水平很低
百草枯中毒诊治共识与规范
河北医科大学第二医院急诊科 田英平
急性百草枯中毒诊治专家共识
• 我国急性中毒第一个急诊同道的共识 • 中国急诊医师协会,中国急救医学 ,2013,33(6):484-489 • 共识与指南?所知有限,为共识。 • 共识讨论两年余,共识可否成为规范? • 尚有距离!
共识解读与规范
坚持了服毒量分级依据 服毒量判断困难与局限 通常一口按致死量处理是合适的 血尿毒检的意义与现实距离
分级标准的认同共识
轻型 摄入百草枯的量<20毫克/kg体重 中重型 摄入百草枯量>20 ~40毫克/kg体重 暴发型 摄入百草枯的量>40毫克/kg体重
分级标准的原意与解读
指导治疗,判断预后 防止过度医疗,避免医源性损害 存在局限性:服毒量如何判断
• • • • • • 背景与现状 毒代动力学与 毒理机制 诊断与鉴别诊断 救治措施与原则 知情告知与预后 协会责任与呼吁
规范之PQ中毒命名
命名:急性百草枯中毒(acute paraquat poisoning,APQ),慢性罕见,以示警 觉。 有慢性中毒吗?巴金森病与PQ有关?
诊断之规范
• 必须进行鉴别诊断:毒检方法有局限性 • 疑似诊断、临床诊断、临床确诊界定了 条件。 • 诊断共识应成为规范
共识对诊断条件界定
(完整版)药学英语专业词汇
(完整版)药学英语专业词汇一、药物分类及命名1. 抗生素(Antibiotics)青霉素(Penicillin)头孢菌素(Cephalosporins)大环内酯类(Macrolides)2. 抗病毒药物(Antiviral Drugs)抗流感病毒药物(Antiviral for Influenza)抗艾滋病病毒药物(Antiviral for HIV)3. 抗肿瘤药物(Anticancer Drugs)化疗药物(Chemotherapeutic Agents)靶向治疗药物(Targeted Therapy Drugs)4. 心血管系统药物(Cardiovascular Drugs)抗高血压药物(Antihypertensive Drugs)抗心绞痛药物(Antianginal Drugs)抗心律失常药物(Antiarrhythmic Drugs)5. 消化系统药物(Gastrointestinal Drugs)抗胃溃疡药物(Antigastric Ulcer Drugs)止泻药物(Antidiarrheal Drugs)泻药(Laxatives)6. 中枢神经系统药物(Central Nervous System Drugs)抗抑郁药物(Antidepressants)抗精神病药物(Antipsychotic Drugs)镇痛药物(Analgesics)二、药物剂型及给药途径1. 剂型(Dosage Forms)片剂(Tablets)胶囊(Capsules)注射剂(Injections)2. 给药途径(Routes of Administration)口服(Oral)肌内注射(Intramuscular)静脉注射(Intravenous)三、药物作用及不良反应1. 药物作用(Pharmacological Actions)抗菌作用(Antibacterial Action)抗病毒作用(Antiviral Action)镇痛作用(Analgesic Action)2. 不良反应(Adverse Reactions)过敏反应(Allergic Reactions)胃肠道反应(Gastrointestinal Reactions)肝脏毒性(Hepatotoxicity)四、药学专业英语词汇1. 药理学(Pharmacology)药物代谢(Drug Metabolism)药物动力学(Pharmacokinetics)药效学(Pharmacodynamics)2. 药剂学(Pharmaceutics)制剂工艺(Preparation Technology)药物稳定性(Drug Stability)药物质量控制(Drug Quality Control)3. 药物化学(Medicinal Chemistry)药物合成(Drug Synthesis)药物结构(Drug Structure)药物设计(Drug Design)本文档旨在帮助药学专业学生和从业者掌握药学英语专业词汇,提高专业英语水平,为学术交流和临床实践提供便利。
青少年百草枯中毒后肺移植1_例并文献复习
· 论著·青少年百草枯中毒后肺移植1例并文献复习孟凡杰 张岩 蔡宏飞 孟凡宇 王瑞 崔有斌 陈静瑜 李洋【摘要】 目的 总结百草枯中毒患者中毒后移植时机以及相关处理措施对预后的影响。
方法 回顾性分析1例百草枯中毒行双肺移植术治疗患者的临床资料,总结分析该例患者的临床表现、辅助检查以及诊治经过。
结果 1例17岁青少年在摄入25%百草枯20~30 mL 后出现恶心、呕吐、咳嗽伴全身乏力入院。
患者经对症支持治疗后,氧饱和情况无改善,肺部纤维化持续进展,遂在体外膜肺氧合(ECMO )辅助下行序贯双侧肺移植。
经术后康复治疗,并积极防治并发症,患者于术后50 d 出院。
结论 百草枯中毒后的移植时机可选择在肝肾功能开始恢复时,围手术期主动、有针对性地预防潜在致病性细菌感染,以及早期康复训练有助于改善肺移植受者的预后。
【关键词】 肺移植;百草枯中毒;肺纤维化;呼吸衰竭;体外膜肺氧合;感染;过客淋巴细胞综合征;支气管狭窄【中图分类号】 R617, R563 【文献标志码】 A 【文章编号】 1674-7445(2024)01-0014-06Lung transplantation after paraquat poisoning in an adolescent: one case report and literature review Meng Fanjie *,Zhang Yan, Cai Hongfei, Meng Fanyu, Wang Rui, Cui Youbin, Chen Jingyu, Li Yang. *Department of Thoracic Surgery , the First Bethune Hospital of Jilin University , Changchun 130021, China Correspondingauthor:LiYang,Email:****************.cn【Abstract 】 Objective To summarize the effect of the timing of lung transplantation and related treatment measures on clinical prognosis of patients with paraquat poisoning. Methods Clinical data of a patient with paraquat poisoning undergoing bilateral lung transplantation were retrospectively analyzed. Clinical manifestations, auxiliary examination, diagnosis and treatment of this patient were summarized and analyzed. Results A 17-year-old adolescent was admitted to hospital due to nausea, vomiting, cough and systemic fatigue after oral intake of 20-30 mL of 25%paraquat. After symptomatic support treatment, the oxygen saturation was not improved, and pulmonary fibrosis continued to progress. Therefore, sequential bilateral lung transplantation was performed under extracorporeal membrane oxygenation (ECMO). After postoperative rehabilitation and active prevention and treatment for postoperative complications, the patient was discharged at postoperative 50 d. Conclusions The timing of lung transplantation after paraquat poisoning may be selected when the liver and kidney function start to recover. Active and targeted prevention of potential pathogen infection in perioperative period and early rehabilitation training contribute to improving clinical prognosis of lung transplant recipients.【Key words 】 Lung transplantation; Paraquat poisoning; Pulmonary fibrosis; Respiratory failure; Extracorporeal membrane oxygenation; Infection; Passenger lymphocyte syndrome; Bronchial stenosisDOI: 10.3969/j.issn.1674-7445.2023175基金项目:吉林省重点研发计划项目(JJKH20211163KJ );吉林省市厅局级重点研发计划项目(2021JC013)作者单位: 130021 长春,吉林大学白求恩第一医院胸外科(孟凡杰、张岩、蔡宏飞、孟凡宇、王瑞、崔有斌、李洋);南京医科大学附属无锡人民医院肺移植中心(陈静瑜)作者简介:孟凡杰(ORCID 0009-0005-3398-0994),硕士研究生,研究方向为肺移植,Email :*****************通信作者:李洋(ORCID 0000-0001-8523-5332),博士,主任医师,研究方向为肺移植及肺癌,Email :****************.cn第 15 卷 第 1 期器官移植Vol. 15 No.1 2024 年 1 月Organ Transplantation Jan. 2024 百草枯是一种价格低廉、无残留、不污染环境的快速灭生性除草剂,对人毒性极高。
孙艳-2014百草枯中毒泰山共识
五、诊断与鉴别诊断-分级标准
重度中毒:具备下列之一: ( a)急性化学性肺水肿(见GBZ73—2009) ( b)急性呼吸窘迫综合征(见GBZ73—2009) ( c)纵隔气肿、气胸(见GBZ73—2009)或皮下气肿: ( d)胸腔积液或弥漫性肺纤维化 ( e)急性重度中毒性肾病(见GBZ79—2013) ( f)多器官功能障碍综合征(见GBZ77—2002) ( g)急性中度或重度中毒性肝病(见GBZ59—2010)。 早期尿液快速半定量检测百草枯浓度>30μg/ml
血液净化治疗
六、治疗-糖皮质激素
糖皮质激素是治疗百草枯中毒的主要治疗药物,早 期足量糖皮质激素治疗首选甲泼尼龙,重症患者可 给予甲泼尼龙每日500~1000mg冲击治疗,连用3 ~5d后,根据病情逐渐减量。
六、治疗-抗凝及抗氧化治疗
百草枯中毒可伴有肺部微循环障碍,血浆D-二聚体 升高,因此积极给予抗凝治疗有助于改善病情。可 给予低分子肝素5000U,皮下注射,每日1次。有 出血倾向者暂缓使用。还原型谷胱甘肽可有效对抗 百草枯的过氧化损伤,剂量2.4g,静脉滴注,每日 1次
关于其机制的研究
百草枯对机体抗氧化防御系统的毒性作用,百草枯毒性的主要 分子机制是对机体氧化-还原系统的破坏和细胞内的氧化应激反 应。 百草枯引起的细胞因子变化,细胞因子在百草枯中毒大鼠急性 肺损伤致肺纤维化中可能起关键的作用。 百草枯引起的基因表达变化,基因表达改变可能会成为以后百 草枯中毒肺损伤的研究方向之一。 百草枯肺损伤可能与联吡啶阳离子产生胞内钙超载有关。 内皮素可能与百草枯中毒导致的多器官功能衰竭有关,可作为 评价多器官功能衰竭程度的临床指标之一。
百草枯中毒,我们真救得了么?
导泻
导泻:20%甘露醇250mL、硫酸者立即脱去污染衣物,肥皂水和清水彻底清洗 皮肤毛发 眼部污染用流动清水冲洗至少15~20 min,专科处理
治 疗
促进毒物排出 补液利尿
补液量4000mL以上,根据心肺肾功能、尿量调节 尿量维持在1-2mL/kg.h
暴发型:摄入量>40mg/kg,严重胃肠道症 状,l-4d死于多器官功能衰竭,极少存活。
诊 断
注意事项 随时间推移,血、尿毒物浓度逐渐降低, 甚至难以测出;
有明确百草枯口服史,即使临床症状轻微, 没有毒检证据,诊断仍成立;毒物接触史 不详,血、尿中检出百草枯,即使临床表 现不典型,诊断也成立;
血液净化
血液灌流(HP)作用基本达成共识,尽快实行,2-4hr内 效果较好,根据口服量、血毒物浓度决定灌流次数 血液透析(HD)用于合并肾功能损伤的患者 连续静脉-静脉血液滤过(CVVH)理论上有效,尚需临床 资料验证 血浆置换无效
治 疗
活 性 碳
比表面积 孔径
1000 m2/g 大小不一 广泛 相对小 颗粒易脱落
HA树脂
1500m2/g 可调节,一般在13—15nm之间 相对特异性 大 好
吸附谱
吸附强度 机械强度
主要吸附 物 质 主要适应症
生物相容性
无选择性
各种分子量 药物中毒 差
相对特异选择性
500—50000道尔顿 药物中毒、重型肝炎、尿毒症 好
治 疗
药物治疗 糖皮质激素
非暴发型中重度患者甲泼尼龙15 mg/kg.d(氢化考的 松75 mg/kg.d) 疗程方案有争议,前3天冲击,总疗程21-60d 感染、股骨头坏死副作用
C H3 N
+
住院患者与医护人员产生的矛盾因素及解决办法
态度冷漠 ,缺乏真诚 。医护人员因工作繁忙、任务重 、时间有 限等原 因少与患者沟通 ,因家庭琐事 、体力不支 、精 神疲倦等 因素造成 医护人员对 患者态度冷 漠或缺乏 真诚 。医护人 员 应视 患者 如亲人 、朋友 ,无论 任务再重 ,工作 再忙 ,对患者尽 量用 温和的语 言进行生 活问候或谈 心 ,或 通过友好 的举动 、 真诚 和善的面部表情和身体语言传递关心 和爱心 ,均有利于 患者 对医护人员 的理解 和接纳 ,以便知道 他们 的需求 ,从 而 尽量满足其合理所需。④责任心 差 ,专业技术不精。在临床 工作 中 ,即使护理人员态 度和蔼 ,服务 热情周 到 ,但对患者的 疑问解释不清楚 、病 情变化不 了解 、技术操 作不熟练 ,仍会引 起患者不满 ,造成矛盾恶化 ,甚至投诉 。作为 医务工作者 ,应 严格 执行 查对制 度和无菌 技术 操作规 格 ,时 刻谨 记人命 关 天 ;用药前一定要检查药 品质 量标签 、失 效期 、批 号 、询 问过 敏史 ,巡视病房要认 真细致 ,切忌工 作懒 散 ,玩 忽职守 ;平时 要加强业务学 习 ,不断提 高业务水平和专业技术操作。
患者方面的 因素 :不同患 者 由于 年龄 、性别 、性格 、生活 习惯 、职业 、经济状况 、受教 育程度 ,专业知识 的认识程 度、对 健康的关注等方面的差异 ,对护理和医疗 的需求与期望值也 不尽相 同,相 同的服务 方式对 不同的患者也会导致矛盾的产 生 。因此患者在就诊时和住院期 间,医护人员应 向其宣传有 关疾病的相关知识 ,随时将 疾病治疗 的效果 、不 良反 应和可 能出现 的并发症 、后遗 症等解释清楚 ;另外 ,患者住院期 间医 护人员必须将相关检查 的 目的及费用要 向患者及家 属交代 清楚 ,最 好能 获得他们 的认 可 ,避免可能出现的医疗纠纷 。
急性百草枯中毒致肺损伤的发病机制及治疗
急性百草枯中毒致肺损伤的发病机制及治疗目的:探讨急性百草枯中毒致肺损伤的机制及其治疗方式。
方法:选取我院50例百草枯中毒致肺损伤患者,给予胸片、CT等检查,给予清除毒物、血液净化、药物治疗等综合治疗。
通过资料分析,总结发病机制及治疗方法。
结果:肺间质病变、毛玻璃样变见于绝大多数患者,发生率均远远高于其他病变(P<0.05)。
纵隔病变、心包病变等少见。
治疗后,存活患者动脉血氧分压(PaO2)、氧合指数(PaO2/FiO2)均显著提高(P<0.05);PaO2达90%以上,PaO2/FiO2达400以上,二氧化碳分压(PaCO2)显著减低(P<0.05)。
50例患者中存活29例,死亡率为42%。
结论:百草枯中毒致肺损伤机制较为复杂,综合疗法治疗百草枯中毒肺损伤效果确切,降低了死亡率。
[Abstract] Objective: To investigate the pathogenesis and therapies of lung injury caused by acute Paraquat poisoning. Methods: 50 patients with acute Paraquat poisoning of our hospital were examined with chest radiograph and CT, and treated comprehensively including poison elimination, blood purification and pharmacotherapy. Then the pathogenesis and therapies were concluded through analyzing the data acquired. Results: The interstitial lung disease and ground-glass attenuation were discovered from most of the patients and the incidence was far higher than the other pathologic changes (P<0.05), while the mediastinal pathologic change and pericardial pathologic change occurred rarely. After the treatment, the arterial oxygen tension (PaO2), oxygenation index (PaO2/FiO2) of the survival patients were increased dramatically (P<0.05); PaO2 took over 90% and PaO2/FiO2 over 400, PaCO2 was decreased dramatically (P<0.05). The death rate out of 50 patients was 42%. Conclusion: The pathogenesis of lung injury caused by acute Paraquat poisoning is quite complicated. Adopting comprehensive therapy on this injury has a good curative effect with improving the patients’respiratory function and decreasing the mortality.[Key words] Paraquat; Lung injury; Pathogenesis; Treatment急性百草枯(Paraquat,PQ)為高效有机杂环类接触性脱叶剂和除草剂,但对人畜有极强的毒性,可造成以肺为主的多种脏器严重损伤,致死率极高[1]。
百草枯致肺纤维化关于TGF-β信号转导通路的研究进展
百草枯致肺纤维化关于TGF-β信号转导通路的研究进展摘要:百草枯中毒能引起消化道等多器官功能损伤,尤其具有嗜肺性。
其中毒引起的肺纤维化往往不可逆,参与肺纤维化的众多细胞因子中,TGF-β被认为是致纤维化的关键性细胞因子,本文主要就百草枯致肺纤维化关于TGF-β信号转导通路进行探讨,为治疗肺纤维化开辟潜在途径。
关键词:百草枯;肺纤维化;TGF-β;细胞信号通路百草枯(Paraquat,PQ)又称对草快、克芜踪,化学名1-1-二甲基-4-4-联吡啶阳离子盐,是一种快速灭生性除草剂。
百草枯对人毒性极大,多经口服及皮肤接触中毒,能引起消化道等多器官功能损伤,尤其具有嗜肺性[1],肺中存在着多胺摄取及其转运系统,百草枯有着与多胺类似的结构,可竞争性抑制多胺类物质的摄取和聚集,故肺成为百草枯中毒损害的主要器官,其中毒引起的肺纤维化往往不可逆[2],[3]。
1、百草枯致肺纤维化1.1百草枯中毒发展百草枯自1962年首次作为除草剂使用后,各地报道的PQ中毒病例逐年增加,已成为目前人类急性中毒死亡率最高的除草剂。
口服PQ 已成为目前一种常见的自杀手段[4]。
PQ中毒患者病死率极高,有国外文献称死亡率可达60%~70%[5]。
PQ口服吸收入血后迅速随血液循环分布至全身各组织器官,其中以肺脏含量最高,为其他部位6~10倍[6]。
消化系统为口服百草枯中毒早期症状,可出现口腔粘膜、舌粘膜充血糜烂。
第二阶段,中央区肝细胞、近端肾小管、心肌、骨骼受到损伤。
第三阶段,主要集中在肺组织内,一般在吞服后2~14天明显表现症状。
表现为早期肺泡上皮细胞受损,肺泡内出血水肿,炎症细胞浸润。
百草枯中毒可造成急性肺损伤或急性呼吸窘迫综合征(ARDS),晚期则出现肺泡内和肺间质的纤维化,患者多死于多脏器功能衰竭或呼吸衰竭。
1.2肺纤维化的发展肺纤维化是肺组织受到各种急、慢性肺损伤后组织修复过程中肺成纤维细胞大量增生和细胞外基质(Extracellular matrix, ECM)沉着,最终导致肺组织结构破坏、功能严重受损的一系列复杂过程[7]。
不同剂量激素联用环磷酰胺治疗百草枯中毒
不同剂量激素联用环磷酰胺治疗百草枯中毒朱华【期刊名称】《皖南医学院学报》【年(卷),期】2014(33)4【摘要】Objective: To compare the efficacy and safety of different dosage of methylprednisolone combined with cyclophosphamide for paraquat poison-ing.Methods:Ninety patients admitted to our hospital due to paraquat poisoning were divided into groups of shocktherapy(n=46,treated with high dose of methylprednisolone+cyclophosphamide) and conventional therapy( n=44,managed with conventional dose of methylprednisolone +cyclophospha-mide).The two groups were observed regarding the mortality,incidence of hypoxemia,liver and kidney injury,pulmonary fibrosis and multiple organ fail-ure.Results:The patients received shock therapy significantly had lower mortality in 7 days,incidence of hypoxemia,levels of serum alanine transarninase (ALT) and creatinine(Cre) as well as delayed liver and kidney injury as compared with those managed with conventional dosage (P<0.05 or P <0.01).Although the incidence of pulmonary fibrosis and multiple organ failure in shock group was lower,yet the difference was not significant. Conclusion:High-dose of methylprednisolone plus cyclophosphamide appears a more effective treatment regimen for paraquat poisoning .%目的:探讨不同剂量甲强龙联用环磷酰胺对百草枯中毒的疗效及安全性。
- 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
- 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
- 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
IntroductionPesticide poisoning is common in Taiwan, and a sui-cide attempt is the most common reason for pesticide exposure.1Oral ingestion is the most common pathway of poisoning.1Herbicide is a type of pesticide, and paraquat is a widely used herbicide. Patients with para-quat exposures have a high mortality rate in Taiwan.1Paraquat is highly toxic to humans after oral inges-tion. The initial clinical features of paraquat ingestion include oral ulcer, nausea, vomiting and diarrhea. The patient will usually die from multiorgan failure, such as metabolic acidosis, depression of myocardial and respiratory function with pulmonary fibrosis, and renal or hepatic failure. To the best of our knowledge, intra-venous paraquat poisoning is rare,2–6and the clinical presentation and prognosis of such a scenario would appear to be quite different from that of oral inges-tion.2–6Only 1 case of survival has been reported.4Herein, we present a patient who attempted suicide by means of intravenous paraquat injection.Case ReportThis 28-year-old male was an intravenous drug abuser.He had attempted suicide several times previously,and had received treatment for major depression. He diluted 10mL of 24% paraquat solution with normal saline and injected it into a superficial vein in his left forearm. Whilst the toxic substance was infusing, the skin along the infused vessel developed an erythema-tous appearance and the injection site became painful.The patient was quickly sent to our emergency depart-ment,approximately 2 hours post-exposure. At this time, the patient’s consciousness was clear and he had vital signs with a pulse of 74beats/min, a respiratory rate of 23breaths/min, and blood pressure of 101/65mmHg. He had low body temperature (34.9°C).T he abnormal physical findings for this young man were left arm erythema and induration. Initial complete blood counts and biochemical data, including elec-trolytes, liver- and renal-function tests, revealed nor-mal results, and subsequent urinalysis did not reveal any abnormalities. The patient’s arterial blood-gas ass-essment displayed a PaO 2of 120mmHg in room air.A qualitative urine test confirmed the presence of para-quat, and plasma paraquat concentration (6 hours after injection) was 2.38μg/mL.The patient received 6 consecutive 8-hour sessions of hemoperfusion with activated charcoal; thereafter,urine paraquat level became negative. Intravenous cyclophosphamide treatment (1g) and parenteral pulse therapy with 1g methylprednisolone daily for 3 daysCASE REPORTIntravenous Paraquat PoisoningHuan-Wen Chen 1, Tse-Kai Tseng 2, Liang-Wen Ding 3*Departments of 1Internal Medicine and 2Radiology, and 3Division of Critical Care Medicine,Department of Emergency and Critical Care Medicine, Lotung Poh-Ai Hospital, Yi-Lan, Taiwan, R.O.C.Paraquat is a substance that is highly poisonous to humans. Oral ingestion is the most common pathway of poisoning.Intravenous paraquat poisoning is rare and is strongly associated with attempted suicide. The clinical presentations of such a scenario would appear to be quite different from those of oral ingestion. Herein,we present a case of an intra-venous drug abuser who injected paraquat in an effort to commit suicide. He received hemoperfusion and intravenous cyclophosphamide treatment and parenteral pulse therapy with methylprednisolone. Nevertheless,he suffered from dys-pnea at around 48 hours post-exposure. His condition improved transiently,but he eventually died from severe hypoxia.The findings from our case and those of previously reported cases indicate the grave prognosis and lack of effective management of intravenous paraquat poisoning. [J Chin Med Assoc 2009;72(10):547–550]Key Words:hemoperfusion,herbicide,intravenous poisoning,paraquat,suicide*Correspondence to: Dr Liang-Wen Ding,Division of Critical Care Medicine,Department of Emergency and Critical Care Medicine,Lotung Poh-Ai Hospital,83,Nan Chang Street,Lotung,Yilan 265,Taiwan,R.O.C.E-mail: dinglw@●Received: April 6,2009●Accepted: September 16,2009were undertaken at the same time as hemoperfusion. T he erythematous change, pain and induration of the patient’s left arm progressed gradually. Some blis-ters appeared 4 days after poisoning (Figure 1). The patient suffered from dyspnea around 48 hours post-exposure, and his respiratory rate was 32 breaths/min. At this time, his arterial blood gas displayed a PaO2 value of 49.8mmHg in room air. Follow-up chest X-ray revealed increasing infiltration over bilateral lower-lung fields (Figure 2). Intubation with mechan-ical ventilator support was then performed for acute hypoxic respiratory failure. The patient’s dyspnea sub-sided gradually, and the hypoxemia and chest X-ray results (Figure 3) also appeared to reverse following hemoperfusion and methylprednisolone pulse therapy. Unfortunately, the patient complained of dyspnea on the 10th day of admission. The degree of hypoxemia (PaO2of 51.6mmHg) worsened. At this time, chest X-ray revealed the presence of diffuse fibrotic changes (Figure 4). Pulse therapy was therefore repeated with 1g/day of methylprednisolone for 3 consecutive days in an attempt to suppress the inflammation. In addition, we prescribed oral dexamethasone sub-sequent to the pulse steroid therapy. Although he received this aggressive management, the hypoxemia progressed. On the 21st day subsequent to paraquat poisoning, our patient eventually died from severe hypoxemia.Figure 1.Four days following paraquat poisoning. Several vesi-cles featuring erythematous and indurated changes have devel-oped around the paraquat-infused vessel in the patient’s forearm.Figure 2.Chest radiograph of the patient taken on the 3rd day ofhospitalization shows ill-defined alveolar infiltration predominantin bilateral lower-lung fields with patch consolidation in the rightmiddle lobe of the lung.Figure 4.Chest radiography taken on the 10th day of hospitaliza-tion demonstrates diffuse fibrotic change and reticulonodularopacities in bilateral lungs.Figure 3.Chest radiography taken on the 5th day of hospitaliza-tion depicts great improvement in the patient’s lungs (comparedwith Figure 2).DiscussionParaquat (1,1Ј-dimethyl-4,4Ј-dipyridylium) is an effec-tive herbicide; it is highly toxic to humans and most animals. Unintentional and intentional oral ingestion are the most common pathways of paraquat poisoning in humans. According to a search of the related litera-ture, intravenous paraquat injection is extremely rare.MEDLINE was searched from 1966 to 2008 for cases of intravenous paraquat poisoning in the English-language literature. Only 6 cases were found.2–6The available medical data for the 6 patients and our patient (total, 7 cases) are summarized in Table 1.The symptoms in patients with poisoning include local and systemic toxicological effects. The local clin-ical presentations of intravenous paraquat poisoning differ from those of oral poisoning. Patients with oral paraquat ingestion suffer from oral ulcers, hemoptysis and gastrointestinal (GI) symptoms such as nausea,vomiting, diarrhea and GI bleeding.7T hese symp-toms are caused by direct mucosal irritation.7Patients with intravenous paraquat poisoning do not have direct mucosal irritation, but they might have some GI symptoms such as nausea and vomiting,2,5,6which may be explained by the systemic effect of paraquat on the central nervous system.5Patients with intravenous poisoning have local skin or vessel symptoms.2,5,6In our patient, the injection site developed an erythema-tous condition, and tissue swelling was initially apparent around the site of the injected vessel. T hen, several vesicles of varying sizes appeared. Such findings have also been reported by Hsu et al.5The skin presentation may be explained by local reaction due to the occur-rence of trivial extravasation of paraquat solution to adjacent soft tissue, and/or by local blood-vessel injury,such as phlebitis, related specifically to paraquat injec-tion. The systemic toxicological effects, such as renal hepatic or pulmonary damage, come later than local effects, and are suspected to be dose-dependent and lethal.7The systemic toxicological effects are also sus-pected to have faster onset in patients with intravenous poisoning than in patients with oral ingestion.5,6Although there is no definitive treatment for para-quat poisoning, patients with oral paraquat poisoning require immediate treatment that includes: (1) pre-venting GI absorption; (2) increasing plasma elimina-tion; and (3) preventing pulmonary damage.7Several methods are suggested to prevent pulmonary dam-age, including immunosuppressive therapy, vitamin E,deferoxamine, and N -acetylcysteine.7Although there is a lack of good evidence of the clinical efficacy of immunosuppressive therapy with glucocorticoids and cyclophosphamide in a systematic review,8a current meta-analysis suspects that immunosuppressive therapy is likely to decrease lung fibrosis and mortality.9No treatment protocol was suggested for patients of intra-venous paraquat poisoning. Because of the limited number of cases (Table 1), there are no existing treat-ment protocols to improve the grave outcome for patients with paraquat injection.Proudfoot et al were the first to suggest that paraquat concentration-time ratio before treatmentTable 1.Summary of clinical manifestations and outcomes of patients with intravenous paraquat poisoningPlasma paraquat Predictive Patients Age Sex concentration (μg/mL) survival Management Outcome(yr)(hours after injection)rate (%)*Harley et al 224FNANAForced diuresis +Died after 20 dascorbic acid +superoxide dismutase +α-tocopherol +steroid Hendy et al 342M 2.3 (4)30–50Hemoperfusion ×2SurvivedFernandez et al 421M 0.62 (6)50–70Hemoperfusion +propranolol Died after 15 d Hsu et al 535F 18 (5)<10Hemoperfusion ×2+Died after 4 dcyclophosphamide +pulse therapyHsu et al 537M 19.6 (1)<10Hemoperfusion ×2+Died after 5 dcyclophosphamide +pulse therapy Choi et al 631F 21 (10)<10Hemoperfusion ×2Died after 3 d Present case 28M 2.38 (6)20–30Hemoperfusion ×6+Died after 21 dcyclophosphamide +repeated pulse therapy*According to the formula of Hart et al.12could predict the outcome of poisoning.10Several prediction methods were developed. Five methods were compared in a large cohort study, and these methods are likely to be accurate in predicting death for patients with paraquat poisoning.11Hart et al created a nomogram with 6 concentration-time curves of about 10–90% survival probability,12and the nomo-gram is easy to use in the emergency department. Sawada et al presented a severity index of paraquat poisoning (SIPP) which was calculated according to the serum level of paraquat,13and the serum concen-trations were lower than plasma concentration.7We could not calculate the SIPP because we only have the plasma paraquat concentrations of the 6 patients with intravenous paraquat from published reports. Jones developed an equation to predict the probability of survival for any specific time,14but it is too complex to be of practical use in the emergency department. Because paraquat enters the body more rapidly by intravenous injection than by oral exposure, the prog-nosis of intravenous paraquat poisoning might be worse than that of oral poisoning. We tried to predict the mortality rate of the 6 patients with intravenous paraquat according to the formula of Hart et al,12and 5 of the 6 patients were considered to have a very high mortality rate (Table 1).2–6Six of the 7 patients (including the present case) did not survive after aggressive treatment (Table 1).2–6Only 1 miraculous case survived from severe pulmonary damage due to paraquat administered intravenously and orally.2The predictive mortality method according to the formula of Hart et al12seems to be suitable for use with cases of intravenous paraquat. However, as there is an inade-quate number of cases who survived, we cannot test the survival prediction ability of Hart et al’s nomogram.In conclusion, intravenous paraquat poisoning is rare, and patients may manifest with a variety of symp-toms including initial dermal changes. These symptoms often appear immediately subsequent to paraquat injection. The prognosis of intravenous paraquat poi-soning is graver than that of oral poisoning. Further experimental and clinical trials are required to search for an effective treatment for patients suffering from intravenous paraquat poisoning.References1.Yang CC, Deng JF. Pattern of acute pesticide poisoning inTaiwan. J To xico l Clin To xico l2003;41:523. (XXII Inter-national Congress of the European Association of Poison Centres and Clinical Toxicologists, Rome, Italy.)2.Harley JB, Grinspan S, Root RK. Paraquat suicide in a youngwoman: results of therapy directed against the superoxide radi-cal. Yale J Biol Med1977;50:481–8.3.Hendy MS, Williams PS, Ackrill P. Recovery from severe pul-monary damage due to paraquat administered intravenously and orally. Thorax1984;39:874–5.4.Fernandez P, Bermejo AM, Lopez-Rivadulla M, Cruz A,Rodriguez E, Otero A. A fatal case of parenteral paraquat poi-soning. Forensic Sci Int1991;49:215–24.5.Hsu HH, Chang CT, Lin JL. Intravenous paraquat poisoning-induced multiple organ failure and fatality: a report of two cases. J Toxicol Clin Toxicol2003;41:87–90.6.Choi Y, Cho K, Yoon S, Lee H, Choi Y. A case of paraquatintoxication caused by intravenous injection. Am J Emerg Med 2008;26:836.e3–4.7.Dinis-Oliveira RJ, Duarte JA, Sánchez-Navarro A, Remião F,Bastos ML, Carvalho F. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit Rev Toxicol 2008;38:13–71.8.Eddleston M, Wilks MF, Buckley NA. Prospects for treatmentof paraquat-induced lung fibrosis with immunosuppressive drugs and the need for better prediction of outcome: a system-atic review. QJM2003;96:809–24.9.Agarwal R, Srinivas R, Aggarwal AN, Gupta D. Immuno-suppressive therapy in lung injury due to paraquat poisoning:a meta-analysis. Singapore Med J2007;48:1000–5.10.Proudfoot AT, Stewart MS, Levitt T, Widdop B. Paraquat poi-soning: significance of plasma–paraquat concentrations. Lancet 1979;2:330–2.11.Senarathna L, Eddleston M, Wilks MF, Woollen BH,Tomenson JA, Roberts DM, Buckley NA. Prediction of out-come after paraquat poisoning by measurement of the plasma paraquat concentration. QJM2009;102:251–9.12.Hart TB, Nevitt A, Whitehead A. A new statistical approach tothe prognostic significance of plasma paraquat concentrations.Lancet1984;2:1222–3.13.Sawada Y, Yamamoto I, Hirokane T, Nagai Y, Satoh Y, UeyamaM. Severity index of paraquat poisoning. Lancet1988;1:1333.14.Jones AL, Elton R, Flanagan R. Multiple logistic regressionanalysis of plasma paraquat concentrations as a predictor of out-come in 375 cases of paraquat poisoning. QJM1999;92:573–8.。